Published Date : Jan 12, 2016
ALBANY, NY, Jan 12, 2016: MarketResearchReports.biz has recently announced the addition of a new market research report to their comprehensive database of research studies. The research report, titled “Regenerative Medicine Market in the US 2016 - 2020,” provides an in-depth reports of the U.S. regenerative medicine market including the market overview, product segmentation, market drivers and restraints, challenges and opportunities, and vendor reports. The report has also listed inputs and recommendations of industry experts and professionals to guide the existing as well as new players in designing their business strategies.
Regenerative medicine is a kind of medical process that make use of cell-based therapeutics or laboratory-grown human tissue for the purpose of treating injured or diseased human tissues, cells, or organs. According to the research study, the U.S. market for regenerative medicine is anticipated to witness rapid growth, exhibiting an exponential 33% CAGR between 2016 and 2020.
This rapid growth of this market can be attributed to the increased demand for stem cell and tissue engineered products, which are used while treating different disorders and diseases. The tremendous potential of these medicines that are used for regenerating diseased tissues or organs is the most important factor that is expected to boost the demand of regenerative medicines in the U.S. market. In addition, the rising applications of stem cells and developments in the field of nanotechnology are expected to fuel the growth of this market throughout the forecast period.
For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/499764
On the basis of application, the U.S. regenerative medicine market is segmented into dermatology, cardiovascular, ocular, and musculoskeletal. In 2015, the dermatology segment accounted for a massive share of 51% in the U.S. regenerative medicine market and is expected to be in that position throughout the forecast period. The dermatology segment comprises several treatments including chronic wounds and burns, which require responsive treatment. Several factors such as the growing geriatric population, rising prevalence of obesity and diabetes, and an increase in life expectancy are expected to boost the demand for this segment in the coming years.
In the last section, the research report has provided a complete reports of the competitive landscape of the U.S. regenerative medicine market. The reports included in this report covers company overview, contact information, inception details, financial overview, business strategies, and the recent developments. The key vendors of this market are Reprocell, Stryker, Organogenesis, Mesoblast, and Acelity. Some of the other vendors mentioned in the research report are Shire Regenerative Medicine, Baxter, Humacyte, BioRestorative Therapies, Cytori Therapeutics, Allosource, and Vericel. The U.S. market for regenerative medicine is highly competitive and fragmented owing to the several key players operating in this market. The competitive nature of the market has encouraged these players to spend extensively on research and development and innovations in products so as to attain a leading position in the next few years.
To order report Call Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org